Article Text

Download PDFPDF
Developing a privacy-preserving deep learning model for glaucoma detection: a multicentre study with federated learning
  1. An Ran Ran1,
  2. Xi Wang2,3,4,
  3. Poemen P Chan1,5,
  4. Mandy O M Wong5,
  5. Hunter Yuen5,
  6. Nai Man Lam5,
  7. Noel C Y Chan6,7,
  8. Wilson W K Yip6,7,
  9. Alvin L Young6,7,
  10. Hon-Wah Yung8,
  11. Robert T Chang9,
  12. Suria S Mannil9,
  13. Yih-Chung Tham10,11,12,
  14. Ching-Yu Cheng10,11,12,
  15. Tien Yin Wong10,13,14,
  16. Chi Pui Pang1,
  17. Pheng-Ann Heng3,
  18. Clement C Tham1,5,
  19. Carol Y Cheung1
  1. 1 Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China
  2. 2 Zhejiang Lab, Hangzhou, China
  3. 3 Department of Computer Science and Engineering, The Chinese University of Hong Kong, Hong Kong SAR, China
  4. 4 Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California, USA
  5. 5 Hong Kong Eye Hospital, Hong Kong SAR, China
  6. 6 Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong SAR, China
  7. 7 Ophthalmology and Visual Sciences, Alice Ho Miu Ling Nethersole Hospital, Hong Kong SAR, China
  8. 8 Tuen Mun Eye Centre, Hong Kong SAR, China
  9. 9 Ophthalmology, Stanford University School of Medicine, Stanford, California, USA
  10. 10 Singapore Eye Research Institute, Singapore National Eye Centre, Singapore
  11. 11 Duke-National University of Singapore Medical School, Singapore
  12. 12 Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
  13. 13 Tsinghua University, Beijing, China
  14. 14 School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Beijing, China
  1. Correspondence to Dr Carol Y Cheung, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China; carolcheung{at}cuhk.edu.hk

Abstract

Background Deep learning (DL) is promising to detect glaucoma. However, patients’ privacy and data security are major concerns when pooling all data for model development. We developed a privacy-preserving DL model using the federated learning (FL) paradigm to detect glaucoma from optical coherence tomography (OCT) images.

Methods This is a multicentre study. The FL paradigm consisted of a ‘central server’ and seven eye centres in Hong Kong, the USA and Singapore. Each centre first trained a model locally with its own OCT optic disc volumetric dataset and then uploaded its model parameters to the central server. The central server used FedProx algorithm to aggregate all centres’ model parameters. Subsequently, the aggregated parameters are redistributed to each centre for its local model optimisation. We experimented with three three-dimensional (3D) networks to evaluate the stabilities of the FL paradigm. Lastly, we tested the FL model on two prospectively collected unseen datasets.

Results We used 9326 volumetric OCT scans from 2785 subjects. The FL model performed consistently well with different networks in 7 centres (accuracies 78.3%–98.5%, 75.9%–97.0%, and 78.3%–97.5%, respectively) and stably in the 2 unseen datasets (accuracies 84.8%-87.7%, 81.3%-84.8%, and 86.0%–87.8%, respectively). The FL model achieved non-inferior performance in classifying glaucoma compared with the traditional model and significantly outperformed the individual models.

Conclusion The 3D FL model could leverage all the datasets and achieve generalisable performance, without data exchange across centres. This study demonstrated an OCT-based FL paradigm for glaucoma identification with ensured patient privacy and data security, charting another course toward the real-world transition of artificial intelligence in ophthalmology.

  • Glaucoma

Data availability statement

Data are available upon reasonable request. The study protocol, the statistical analysis plan and the packaged model are available upon reasonable request. Such requests are decided on a case-by-case basis. Proposals should be directed to carolcheung@cuhk.edu.hk.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data are available upon reasonable request. The study protocol, the statistical analysis plan and the packaged model are available upon reasonable request. Such requests are decided on a case-by-case basis. Proposals should be directed to carolcheung@cuhk.edu.hk.

View Full Text

Footnotes

  • ARR and XW are joint first authors.

  • P-AH, CCT and CYC contributed equally.

  • Contributors CYC and ARR conceived and designed the study. CCT, C-PP, HY and NML supervised the study design and data collection. XW developed and validated the deep learning model supervised by P-AH with the help of clinical input from ARR, CYC, PPC, NCYC, MOMW and CCT. PPC, MOMW and CCT provided data from Chinese University of Hong Kong Eye Centre and Hong Kong Eye Hospital. NCYC, WWKY and ALY provided data from PWH and AHNH. H-WY provided the data from TMEC. SSM and RTC provided the data from the Stanford. Y-CT, C-YC and TYW provided the data from SERI. ARR performed the statistical analysis. ARR and XW wrote the initial draft. CYC is guarantor.

  • Funding This study was funded by the Innovation and Technology Fund, Hong Kong SAR, China (MRP/056/20X).

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Linked Articles

  • Highlights from this issue
    Frank Larkin